Nurix Therapeutics, Inc. (NRIX)

NASDAQ

$25.33

$-0.18

(-0.71%)

Previous Close: ⁦$25.51⁩

Market Closed

Nurix Therapeutics, Inc. (NRIX) Live Price Chart

Last updated: ⁦2026-10-24 07:43:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Nurix Therapeutics, Inc. (NRIX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $25.33, with a market capitalization of $2.79B and a P/E ratio of 9.45. Over the past 52 weeks, its price has ranged from $10.38 to $28.23. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.79B
Open	$25.22
Day's High	$52.38
Day's Low	$4.22
Previous Close	$25.51
Volume	1.63M
Average Volume	1.64M
P/E Ratio	9.45
52-Week High	$28.23
52-Week Low	$10.38
Dividend Yield	--
Earnings Date	--

Nurix Therapeutics, Inc. (NRIX) Latest Closing Stock Price

Nurix Therapeutics, Inc. (NRIX) last closed at $25.51 as of 2026-10-23 23:31:00, unchanged from the previous close of $25.51.

During the latest regular trading session, NRIX traded between $4.22 and $52.38, with a volume of 1.63M shares. The closing price was near the middle and near the upper end of its 52-week range.

Nurix Therapeutics, Inc. (NRIX) 7-Day Stock Price Change

Over the past seven days, Nurix Therapeutics, Inc. (NRIX) moved from $24.95 to $25.33, representing a gain of 1.54% ($0.38).

The stock traded between $23.61 and $26.34 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 3.13 million shares, up versus the previous seven-day period, indicating higher trading activity.

NRIX 52-Week Price Position

Position in Range: 83.8%

52W Low$10.38

52W High$28.23

NRIX is currently trading at $25.33, placing it 83.8% of the way from its 52-week low of $10.38 to its 52-week high of $28.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Nurix Therapeutics, Inc. (NRIX)?

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Nurix Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	357
Exchange	NASDAQ
Company Website	https://www.nurixtx.com

How to Buy Nurix Therapeutics, Inc. (NRIX) Stock on MEXC

Eligible investors can buy real shares of Nurix Therapeutics, Inc. (NRIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NRIX and Place Your Order

Open the RealStocks trading page and search for NRIX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Nurix Therapeutics, Inc. (NRIX) stock price today?

Nurix Therapeutics, Inc. (NRIX) is currently trading at $ 25.33, down 0.69% ($0.18) from the previous close of $ 25.51. Intraday prices update in real time during regular trading hours.

2.Is NRIX stock going up or down today?

As of 2026-10-23 23:31:00, NRIX is trading at $ 25.33, down 0.69% ($0.18) from its previous close of $ 25.51. The stock has traded between $ 4.22 and $ 52.38 during today’s regular session. Past price movements do not guarantee future results.

3.What is NRIX pre-market price?

As of 2026-10-23 23:31:00, NRIX is trading at $ 25.54 in pre-market trading, up 0.11% ($0.03) from the previous close of $ 25.51. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NRIX after-hours price?

As of 2026-10-23 23:31:00, NRIX is trading at $ 25.93 in after-hours trading, up 1.63% ($0.41) from the regular-session close of $ 25.51. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NRIX stock trading now?

NRIX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NRIX sit relative to its 52-week high and low?

Over the past 52 weeks, NRIX has traded between a low of $ 10.38 and a high of $ 28.23. At $ 25.33, the stock is positioned 83.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Nurix Therapeutics, Inc. in?

Nurix Therapeutics, Inc. (NRIX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Nurix Therapeutics, Inc.'s market capitalization and where is it listed?

Nurix Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 2.79B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NRIX valued in terms of P/E ratio and EPS?

NRIX trades at a P/E ratio of 9.45, based on trailing-twelve-month EPS of $ 2.70. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Nurix Therapeutics, Inc. pay a dividend?

Nurix Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.